pentoxiverine Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Pentoxyverine is a non-opioid antitussive used to prevent cough caused by common cold. It is used as an active ingredient of several oral over-the-counter cough suppressants alone or in combination with other medications, especially decongestants. Certuss is a combination of pentoxyverine and guaifenesin. Pentoxyverine is FDA pregnancy category C drug. Known as anticonvulsant, and spasmolytic agent.   NCATS

Chemistry

More Chemistry

Pharmacology

Alternative names

1-phenylcyclopentanecarboxylic acid,2-(2-(diethylamino)ethoxy)ethyl ester | 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate | carbetapentane | carbetapentane 1,5-napthalenedisulfonate (2:1) | carbetapentane 2,6-napthalenedisulfonate (2:1) | carbetapentane citrate | carbetapentane tannate | pentoxiverine | pentoxyverine | pentoxyverine citrate | toclase

Organizations (1)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (1)


 

Sinusitis

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Cough (Phase 1)

Healthy Volunteers (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue